itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Does Oral Chromium Withstand Steroid Hyperglycemia in Postinterventional Ultrasound-guided Sacroiliac Joint Injections in Patients With Diabetes: A Double Blind Randomized Controlled Trial

    22 апреля, 2026

    CONCLUSIONS: Chromium supplementation improves glycemic control and reduces analgesic dependence in patients with diabetes who had an SIJ injection. Chromium supplementation therapy is a safe and cost-effective adjunct to standard diabetes management. →

    Clinical Trials
  • Photobiomodulation in wounds of individuals with diabetes: a nonrandomized pilot study

    22 апреля, 2026

    CONCLUSION: Application of photobiomodulation at an intensity of 2 J/cm² once a week did not produce measurable changes in cytokine gene expression. However, significant reduction in wound area and improvement in tissue repair were observed in patients treated with photobiomodulation. →

    Clinical Trials
  • Industrial AI for the Physical World: Siemens’s Peter Koerte

    22 апреля, 2026

    In this episode of the Me, Myself, and AI podcast, host Sam Ransbotham talks with Peter Koerte, a member of the managing board and chief strategy and technology officer of Siemens, about how industrial AI is quietly transforming the infrastructure that powers everyday life. While consumer AI grabs headlines, Peter explains how artificial intelligence is… →

    Management
  • Beyond the Model — Why Responsible AI Must Address Workforce Impact

    22 апреля, 2026

    For the fifth year in a row, MIT Sloan Management Review and Boston Consulting Group (BCG) have assembled an international panel of AI experts that includes academics and practitioners to help us understand how responsible artificial intelligence (RAI) is being implemented across organizations worldwide. In prior years, we examined organizational RAI maturity; third-party, generative, and… →

    Management
  • How Do Asian–White Biracial People Self-Identify?

    22 апреля, 2026

    Who am I? It’s a basic question that people may occasionally ask themselves during moments of self-reflection. But for many multiracial people in an increasingly diverse America, it’s the kind of question that comes up all the time.  “As you think about people who have multiracial backgrounds, all sorts of interesting questions arise—about who belongs… →

    Management
  • Podcast: Introducing Insight Unpacked, Season 3

    22 апреля, 2026

    Introducing Insight Unpacked Season 3: Can We Still Build a Green Economy? Insight in your inbox Receive our newsletters to keep up with the latest research and ideas from faculty at the Kellogg School of Management. https://insight.kellogg.northwestern.edu/newsletter/insightful-leader In the last decade, we’ve seen powerful people and organizations take on the issue of climate change—making big… →

    Management
  • Building Resilience, One Lap at a Time

    22 апреля, 2026

    Long before his business and teaching career, Carter Cast received an early lesson in what excellence demands.  Before taking on leadership roles at Walmart.com, PepsiCo, and Blue Nile, Cast first chased excellence in a different lane: swimming. In his youth, the clinical professor of strategy at the Kellogg School was an extraordinarily talented swimmer.   He… →

    Management
  • Bright IDEAS-YA Skills Training and Psychosocial Outcomes of Young Adults With Cancer: A Randomized Clinical Trial

    21 апреля, 2026

    CONCLUSIONS AND RELEVANCE: In this randomized clinical trial of Bright IDEAS-YA, intervention participants had significantly reduced distress and improved HRQOL relative to control. These findings suggest that Bright IDEAS-YA may be offered as supportive care for YAs with cancer to improve psychosocial outcomes. →

    Clinical Trials
  • Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial

    21 апреля, 2026

    CONCLUSION: Based on this simulation model, using head-to-head SURMOUNT-5 trial data, tirzepatide (MTD) had lower total costs and higher QALYs compared to semaglutide (MTD). This supports that tirzepatide (MTD) is a cost-effective treatment option for individuals with obesity or overweight compared to semaglutide (MTD). →

    Clinical Trials
  • Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trial

    21 апреля, 2026

    Acquired pure red cell aplasia (aPRCA) is rare and challenging to treat. We investigated the efficacy and safety of sirolimus plus roxadustat in patients with aPRCA (Chinese Clinical Trial Register number, ChiCTR2200065107). We enrolled 82 patients with aPRCA in this prospective single-arm, open-label, multicenter trial between October 2022 and January 2024. Treatment response and safety… →

    Clinical Trials
1 2 3 … 944
Следующая страница